John Lee, MD
Surgical Oncology · Sacramento, CANPI 1427032630
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $523 of the $592 with a category attached, or 88.4%. 6 manufacturers reported payments, led by Intuitive Surgical at 24.9% of the total. That places this record below the midpoint for surgical oncology clinicians in CA, where the typical reported total is $1,777.
Across 7 payments — averaging $84.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$147
- Johnson & Johnson$140
- Springworks Therapeutics, Inc.$113
- Merit Medical Systems Inc$95
- AstraZeneca$68
- Tempus AI, Inc$28
What the payments were for
- Food & beverage$52388%
- Education$6812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $147 |
| Johnson & Johnson | 2 | $140 |
| Springworks Therapeutics, Inc. | 1 | $113 |
| Merit Medical Systems Inc | 1 | $95 |
| AstraZeneca | 1 | $68 |
| Tempus AI, Inc | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$147
- N/A$121
- OGSIVEO$113
How this compares
$592 in reported general payments places this provider in the 30th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $79 |
| Levothyroxine Sodium | 11 | $58 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $32 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Sacramento
- Sepideh GholamiSacramento$32K
- Smit SinglaSacramento$11K
- Afshin BahadorSan Diego$701K
- Amir FathiFresno$255K
- Alexander ChristSanta Monica$239K
- Yanghee WooDuarte$131K
- Michael BouvetSan Diego$118K
- Yuman FongDuarte$87K
- Ronald HurstLos Angeles$76K
- Jason Sicklickla Jolla$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.